There were two reports. One was the consultant's report on medicines that work for Canadians, the business plan. It was commissioned, I believe, by Health Canada. The other is the blueprint. Can you just tell us how involved you were in both those reports and whether you agreed with the recommendations and whether you see anything changing?
On February 7th, 2008. See this statement in context.